Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06378190
Status:
RECRUITING
Last Update Posted:
2024-06-03
First Post:
2024-02-16
Brief Title:
Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor CAR T-cell Therapy Produced by a New Technology
Sponsor:
Instituto de Investigación Biomédica de Salamanca
Organization:
Instituto de Investigación Biomédica de Salamanca
Organization Data
Organization:
Instituto de Investigación Biomédica de Salamanca
Class:
OTHER
Study ID:
TranspoCART19
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Instituto de Investigación Biomédica de Salamanca
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Fundación para la Investigación Biomédica del Hospital 12 de Octubre | UNKNOWN |
| Spanish Clinical Research Network - SCReN | NETWORK |
| Fundación Canaria de Investigación Sanitaria | OTHER |